⌘K

Login Start Free

Home/Filings/5/0000899243-19-003318

5//SEC Filing

Krasner Alan Seth 5

Accession 0000899243-19-003318

CIK 0001658247other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:25 PM ET

Size

4.9 KB

Accession

0000899243-19-003318

Insider Transaction Report

Form 5

Period: 2018-12-31

Crinetics Pharmaceuticals, Inc.CRNX

Krasner Alan Seth

Chief Medical Officer

Transactions

Other
Common Stock
2018-11-20$14.45/sh+1,470$21,242→ 3,470 total

Footnotes (1)

[F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

Documents

1 file

5
doc5.xmlPrimary
FORM 5 SUBMISSION

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1

filerCIK 0001435775

Filing Metadata

Form type: 5
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:25 PM ET
Size: 4.9 KB

View on SEC.gov